These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 17120733)

  • 1. The value of p63 and CK5/6 expression in the differential diagnosis of ductal lesions of breast.
    Ding Y; Ruan Q
    J Huazhong Univ Sci Technolog Med Sci; 2006; 26(4):405-7. PubMed ID: 17120733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined evaluation of CK5/6, ER, p63, and MUC3 for distinguishing breast intraductal papilloma from ductal carcinoma in situ.
    Furuya C; Kawano H; Yamanouchi T; Oga A; Ueda J; Takahashi M
    Pathol Int; 2012 Jun; 62(6):381-90. PubMed ID: 22612506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The significance of combined CK5/6 and p63 immunohistochemistry in predicting the risks of subsequent carcinoma development in intraductal papilloma of the breast.
    Yang Y; Suzuki K; Abe E; Li C; Uno M; Akiyama F; Yamauchi H; Kikuchi M; Ohde S; Deshpande G; Shibahara Y; Nakamura Y; Sasano H
    Pathol Int; 2015 Feb; 65(2):81-8. PubMed ID: 25572436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Value of CK5/6, CK14, ER and PR detection in differential diagnosis of intraductal proliferative lesions of the breast].
    Niu F; Wang L; Zhang W; Lyu S; Niu Y
    Zhonghua Zhong Liu Za Zhi; 2015 Oct; 37(10):749-52. PubMed ID: 26813593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical staining of papillary breast lesions.
    Troxell ML; Masek M; Sibley RK
    Appl Immunohistochem Mol Morphol; 2007 Jun; 15(2):145-53. PubMed ID: 17525625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The diagnostic utility of CK5/6 and p63 in fine-needle aspiration of the breast lesions diagnosed as proliferative fibrocystic lesion.
    Al-Maghraby H; Ghorab Z; Khalbuss W; Wong J; Silverman JF; Saad RS
    Diagn Cytopathol; 2012 Feb; 40(2):141-7. PubMed ID: 22246930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The predictive ability of a CK5/p63/CK8/18 antibody cocktail in stratifying breast papillary lesions on needle biopsy: an algorithmic approach works best.
    Reisenbichler ES; Adams AL; Hameed O
    Am J Clin Pathol; 2013 Dec; 140(6):767-79. PubMed ID: 24225742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of immunohistochemistry for smooth-muscle actin, p63, CD10 and cytokeratin 14 in the differential diagnosis of papillary lesions of the breast.
    Tse GM; Tan PH; Lui PC; Gilks CB; Poon CS; Ma TK; Law BK; Lam WW
    J Clin Pathol; 2007 Mar; 60(3):315-20. PubMed ID: 16698948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen Receptor and Cytokeratin 5 Are Reliable Markers to Separate Usual Ductal Hyperplasia From Atypical Ductal Hyperplasia and Low-Grade Ductal Carcinoma In Situ.
    Martinez AP; Cohen C; Hanley KZ; Li XB
    Arch Pathol Lab Med; 2016 Jul; 140(7):686-9. PubMed ID: 27116088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunostaining of ∆Np63 (using the p40 antibody) is equal to that of p63 and CK5/6 in high-grade ductal carcinoma in situ of the breast.
    Sailer V; Lüders C; Kuhn W; Pelzer V; Kristiansen G
    Virchows Arch; 2015 Jul; 467(1):67-70. PubMed ID: 25850754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical distinction of invasive from noninvasive breast lesions: a comparative study of p63 versus calponin and smooth muscle myosin heavy chain.
    Werling RW; Hwang H; Yaziji H; Gown AM
    Am J Surg Pathol; 2003 Jan; 27(1):82-90. PubMed ID: 12502930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of c-kit in common benign and malignant breast lesions.
    Kondi-Pafiti A; Arkadopoulos N; Gennatas C; Michalaki V; Frangou-Plegmenou M; Chatzipantelis P
    Tumori; 2010; 96(6):978-84. PubMed ID: 21388062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinicopathologic and immunohistochemical study of 187 cases of intraductal papillary neoplasm of breast].
    Zhang H; Xiong Y; Zhang S; Zhang Y; Wang YH; Li T
    Zhonghua Bing Li Xue Za Zhi; 2011 Nov; 40(11):726-31. PubMed ID: 22336153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comedo-DCIS is a precursor lesion for basal-like breast carcinoma: identification of a novel p63/Her2/neu expressing subgroup.
    Shekhar MP; Kato I; Nangia-Makker P; Tait L
    Oncotarget; 2013 Feb; 4(2):231-41. PubMed ID: 23548208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of immunocytochemistry using a Breast Marker antibody cocktail targeting P63/cytokeratin7/18/cytokeratin5/14 for fine needle aspiration of the breast: a retrospective cohort study of 139 cases.
    Tanaka S; Kanomata N; Teramura K; Wakita K; Kunihisa T; Yano Y; Moriya T; Hayashi Y
    Cytopathology; 2016 Dec; 27(6):465-471. PubMed ID: 27060708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of immunohistochemical staining in breast papillary neoplasms of cytokeratin 5/6 and p63 in core needle biopsies and surgical excisions.
    Koo JS; Kim MJ; Kim EK; Park BW
    Appl Immunohistochem Mol Morphol; 2012 Mar; 20(2):108-15. PubMed ID: 22553810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical use of a P63/cytokeratin7/18/cytokeratin5/14 antibody cocktail in diagnostic breast pathology.
    Reisenbichler ES; Ross JR; Hameed O
    Ann Diagn Pathol; 2014 Dec; 18(6):313-8. PubMed ID: 25224390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The value of immunohistochemical expression of Ki-67 and CD34 in differentiating ductal carcinoma in situ from ductal carcinoma in situ-like invasive breast cancer].
    Pan XY; Wu JK; Lang ZQ; Qu L; Jiang L
    Zhonghua Bing Li Xue Za Zhi; 2022 Sep; 51(9):838-842. PubMed ID: 36097899
    [No Abstract]   [Full Text] [Related]  

  • 19. The role of cytokeratin 5/6 as an adjunct diagnostic tool in breast core needle biopsies.
    Nofech-Mozes S; Holloway C; Hanna W
    Int J Surg Pathol; 2008 Oct; 16(4):399-406. PubMed ID: 18499686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of immunohistochemistry in the differential diagnosis of papillary lesions of the breast.
    Tse GM; Tan PH; Moriya T
    J Clin Pathol; 2009 May; 62(5):407-13. PubMed ID: 19126567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.